Study of BGB-11417 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Clinical trial NCT05479994 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05479994
Sponsor: BeiGene
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia Lymphoma Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Small Lymphocytic Lymphoma Relapsed Chronic Lymphocytic Leukemia

Start date: 2022-10-25
Primary completion: 2025-01-24
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.